Anxiety And Depression clinical trials

Explore recruiting anxiety and depression clinical trials.

Recruiting anxiety and depression studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Anxiety And Depression trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase IIb, randomized, double-blind, multicenter study evaluating the efficacy of botulinum toxin versus placebo on pain and health related quality of life of patients with piriformis muscle syndrome

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Strategic treatment Pause of first-line Immune Check point inhibitor + Inhibitor in good or only one adverse prognostic factor in intermediate risk metastatic renal cell carcinoma (mRCC) with an objective response: a randomized, non-inferiority phase III study - SPICI

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter, randomized, double-blind, and placebo-controlled clinical trial to assess the efficacy and safety of donepezil versus placebo in mild cognitive impairment associated with Parkinson's disease.

Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

KARMA - INtenSive care TreAtmeNT with adjuvant KetAmine and Recovery after Mechanical ventilAtion: a multicenter doubleblind randomized controlled trial

France

Phase II and Phase III (Integrated) EU CTIS Study details

Improving the empowerment in patients with severe breast fibrosis radio-induced treated by Pravastatin : benefit of e-PROs (electronic « Patient Reported Outcome ») on breast-related quality of life

France

Therapeutic exploratory (Phase II) EU CTIS Study details

TestOsterone TreatmEnt on Neuroprotection and Myelin Repair in Relapsing Remitting Multiple Sclerosis (TOTEM-RRMS)

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Anxiety And Depression trials by city

Anxiety And Depression in Toronto Anxiety And Depression in Vancouver Anxiety And Depression in Montreal Anxiety And Depression in Calgary Anxiety And Depression in Edmonton Anxiety And Depression in Ottawa Anxiety And Depression in Winnipeg Anxiety And Depression in Quebec City Anxiety And Depression in Hamilton Anxiety And Depression in Kitchener Anxiety And Depression in London Anxiety And Depression in Halifax Anxiety And Depression in New York Anxiety And Depression in Los Angeles Anxiety And Depression in Chicago Anxiety And Depression in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease